Clinical Trials Browser

Phase 2 × efatutazone × Gastrointestinal × Clear all

NCT00986440 2020-11-05

Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy

Phase 2 Terminated

84 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms

NCT00967616 2020-05-04

Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy

Phase 2 Completed

100 enrolled 13 charts

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms